Cargando…
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
BACKGROUND: Although vascular endothelial growth factor A (VEGF-A) is known to play a key role in causing retinal edema, whether and how VEGF-A induces intracellular edema in the retina still remains unclear. METHODS: Sprague-Dawley rats were rendered diabetic with intraperitoneal injection of strep...
Autores principales: | Wang, Tianqin, Zhang, Chaoyang, Xie, Hai, Jiang, Mengmeng, Tian, Haibin, Lu, Lixia, Xu, Guo-Tong, Liu, Lin, Zhang, Jingfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053282/ https://www.ncbi.nlm.nih.gov/pubmed/33865457 http://dx.doi.org/10.1186/s40662-021-00237-3 |
Ejemplares similares
-
Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy
por: Jiang, Mengmeng, et al.
Publicado: (2022) -
Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema
por: Qin, Shiyue, et al.
Publicado: (2021) -
VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021) -
Effects of anti-VEGF agents on rat retinal Müller glial cells
por: Guo, Bin, et al.
Publicado: (2010) -
Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)